Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RSPH1-DT encodes a long non-coding RNA, distinct from the protein-coding gene RSPH1 (radial spoke head component 1). RSPH1-DT has no established function as a drug target or biomarker. The gene's transcript is annotated in databases, but no known protein, disease-role, or drug interactions have been described. Caution is warranted when searching for therapeutic relevance, as much literature confounds RSPH1-DT with RSPH1, which is implicated in ciliary function and disease but is a structurally and functionally distinct protein-coding gene[5][6]. If you seek information about the disease-relevant target, use “Radial spoke head component 1 (RSPH1)” rather than “RSPH1-DT.”
None known
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RSPH1 divergent transcript (RSPH1-DT).